Inventor · disambiguated record
Feng Tang
Also filed as: TANG FENG · TANG FENG-YAO
3 granted patents·14 pending applications·23 citations·filing 2007–2023
58Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS6NANJING ZAIMING PHARMACEUTICAL CO LTD2UNIV CHINA MEDICAL2HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO LTD1JIANGSU SIMCERE PHARM CO LTD1
Top patents by PatentIndex Score
17 records- 0188US8084621B23-Pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives and uses thereofTANG FENG·Filed 2007·Granted Dec 27, 2011·23 cites·11 claims
- 0261US2025345444A1Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof in preparation of site-directed drug conjugateSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 0359US2025122221A1Six-membered cyclothiazole compound and use thereofNANJING ZAIMING PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0459US2025304717A1Camptothecin derivative and ligand-drug conjugateHAINAN SIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0559US2024197900A1Disaccharide linker, disaccharide-small molecule drug conjugate and sugar chain fixed-point antibody-drug conjugate, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0658US2025197503A1ANTI-HUMAN PD-Ll AND TLR7 DOUBLE-TARGETING NANOBODY CONJUGATE DRUG AND USE THEREOF IN RESISTING TUMORSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 0758US2024261391A1Tlr7 agonist conjugated peptide-based novel coronavirus nanoemulsion vaccine and preparation thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0857US2024148682A1Method for regulating downstream signaling pathway mediated by activation of trimethylamine-n-oxideUNIV CHINA MEDICAL·Filed 2023·Application pending·0 cites
- 0957US2025009871A1Application of novel coronavirus vaccine peptide and nanoemulsion preparation thereof in prevention of novel coronavirus wild and mutant strainsSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 1055US2025345318A1Compound and use thereof in preventing or treating radiation damageSimcere pharmaceutical co ltd·Filed 2023·Application pending·0 cites
- 1154US2025270227A1Camptothecin derivative, and pharmaceutical composition and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1253US2024124454A1Tricyclic compound and use thereofNANJING ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1352US2023241204A1Polypeptide vaccine coupled with tlr7 agonist for novel coronavirus and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Application pending·0 cites
- 1450US9018242B2Salt form of tyrosine kinase inhibitorJIANGSU SIMCERE PHARMACEUTICAL·Filed 2013·Granted Apr 28, 2015·0 cites·15 claims
- 1550US2024307415A1Steroid compound, and pharmaceutical composition thereof and use thereofJIANGSU SIMCERE PHARM CO LTD·Filed 2022·Application pending·0 cites
- 1647US12264105B2Full-fiber burner brick and preparation method thereofLUYANG ENERGY SAVING MAT CO LTD·Filed 2021·Granted Apr 1, 2025·0 cites·8 claims
- 1745US2013172407A1Inhibition of Cancer Cell Proliferation Using OleoylethanolamideUNIV CHINA MEDICAL·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Feng Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →